Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CV Sciences (CVSI) Operating Expenses (2016 - 2025)

CV Sciences' Operating Expenses history spans 14 years, with the latest figure at $1.9 million for Q3 2025.

  • For Q3 2025, Operating Expenses rose 201.15% year-over-year to $1.9 million; the TTM value through Sep 2025 reached $5.9 million, up 2550.41%, while the annual FY2024 figure was $4.1 million, 4.16% up from the prior year.
  • Operating Expenses for Q3 2025 was $1.9 million at CV Sciences, up from $886000.0 in the prior quarter.
  • Across five years, Operating Expenses topped out at $10.5 million in Q4 2021 and bottomed at -$3.3 million in Q4 2023.
  • The 5-year median for Operating Expenses is $2.5 million (2022), against an average of $2.8 million.
  • The largest annual shift saw Operating Expenses crashed 190.18% in 2023 before it skyrocketed 201.15% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $10.5 million in 2021, then plummeted by 64.73% to $3.7 million in 2022, then tumbled by 190.18% to -$3.3 million in 2023, then skyrocketed by 130.71% to $1.0 million in 2024, then skyrocketed by 81.59% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for CVSI's Operating Expenses are $1.9 million (Q3 2025), $886000.0 (Q2 2025), and $2.2 million (Q1 2025).